1Hauser HP, Bardroff M, Pyrowolakis G, et al. A giant ubiquitinconjugating enzyme related to IAP apoptosis inhibitors. J Cell Biol,1998,141:1415-1422.
2Tamm I, Wang Y, Sausville E, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax,caspases, and anticancer drugs. Cancer Res, 1998,58:5315-5320.
3Suzuki A, Hayashida M, Ito T, et al. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16 (INK4a) and Cdk2/cyclin E complex activation. Oncogene, 2000, 19: 3225-3234.
4Grossman D, McNiff JM, Li F, et al. Expression and targeting of the apoptosis inhibitor, Survivin, in human melanoma. J Invest Dermatol, 1999,113:1076-1081.
3ITO Y,SASAKI Y,HORIMOTO M,et al.Activation of mitogen-activated protein kinases/extracellular signalregulated kinases in human hepatocellular carcinoma[J].Hepatology,1998,27(4):951-958.
4PATEL J H,MCMAHON S B.Bel-2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis[J].J Biol Chem,2007,282(1):5-13.
5CHAN K T,LUNG M L.Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line[J].Cancer Chemother Pharm,2004,53(6):519-526.
6COWLING V H,COLE M D.Turning the tables:Myc activates Wnt in breast cancer[J].Cell Cycle,2007,6(21):2625-2627.
